Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens

Simiso Sokhela, Willem D.F. Venter*, Bronwyn Bosch, Joana Woods, Kaitlyn McCann, Godspower Akpomiemie, Nomathemba Chandiwana, Nkuli Mashabane, Angela Tembo, Bryony Simmons, Samanta Lalla-Edward, Mark J. Siedner, Phumla Sinxadi, Lucas Hermans, Lee Fairlie, Alinda Vos, Elaine Abrams, Jennifer M. Manne-Goehler, Michelle Moorhouse, Polly ClaydenShane Norris, Ambar Qavi, Matthew Chersich, Masebole Masenya, Natasha Arulappan, Andrew Hill*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science